Literature DB >> 2515624

Recognition of gut-associated antigens by immunoglobulin M in the indirect fluorescent antibody test for schistosomiasis mansoni.

A M Deelder1, R J van Zeyl, Y E Fillié, J P Rotmans, W Duchenne.   

Abstract

The specific reactivity of immunoglobulin M antibodies, as measured by a commonly used immunodiagnostic technique for schistosomiasis mansoni, the immunofluorescence assay (IFA) on Rossman-fixed sections of adult worms, was analyzed with monoclonal antibodies. Using monoclonal antibodies directed against 3 major gut-associated antigens, circulating anodic antigen (CAA), circulating cathodic antigen (CCA) and the 32 kDa antigen in blocking experiments, it was demonstrated that the measured IFA reaction was primarily due to reactivity with CCA. After blocking with anti-CCA monoclonal antibody, a mean decrease of fluorescent antibody titres of 95.8%, 92.9% and 83.8% was observed for sera from groups of patients with a recent infection (0-6 months), a static infection (6 months - 5 years), and a chronic infection (over 5 years), respectively. Titres of the group of recently infected patients were, after blocking, significantly lower (P less than 0.05) than those of the group of chronically infected patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2515624     DOI: 10.1016/0035-9203(89)90506-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  5 in total

1.  Schistosoma mansoni: analysis of monoclonal antibodies reactive with gut-associated antigens.

Authors:  G J van Dam; D Kornelis; R J Van Zeyl; J P Rotmans; A M Deelder
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

Review 2.  Schistosome glycoconjugates in host-parasite interplay.

Authors:  C H Hokke; A M Deelder
Journal:  Glycoconj J       Date:  2001-08       Impact factor: 2.916

3.  A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics.

Authors:  Marie-Astrid Hoogerwerf; Jan Pieter R Koopman; Marijke C C Langenberg; Jacqueline J Janse; Janneke Kos-van Oosterhoud; Carola Feijt; Simon P Jochems; Claudia J de Dood; Roos van Schuijlenburg; Arifa Ozir-Fazalalikhan; Mikhael D Manurung; Erliyani Sartono; Martha T van der Beek; Béatrice M F Winkel; Petra H Verbeek-Menken; Koen A Stam; Fijs W B van Leeuwen; Pauline Meij; Angela van Diepen; Lisette van Lieshout; Govert J van Dam; Paul L A M Corstjens; Cornelis H Hokke; Maria Yazdanbakhsh; Leo G Visser; Meta Roestenberg
Journal:  Nat Med       Date:  2020-02-17       Impact factor: 53.440

Review 4.  The Advances in Molecular and New Point-of-Care (POC) Diagnosis of Schistosomiasis Pre- and Post-praziquantel Use: In the Pursuit of More Reliable Approaches for Low Endemic and Non-endemic Areas.

Authors:  Marta G Cavalcanti; Aline Fernandes Araujo Cunha; José Mauro Peralta
Journal:  Front Immunol       Date:  2019-05-28       Impact factor: 7.561

5.  Antigen-based diagnosis of Schistosoma infection in travellers: a prospective study.

Authors:  Miriam Casacuberta-Partal; Jacqueline J Janse; Roos van Schuijlenburg; Jutte J C de Vries; Marianne A A Erkens; Kitty Suijk; Mariëlle van Aalst; Jaap J Maas; Martin P Grobusch; Perry J J van Genderen; Claudia de Dood; Paul L A M Corstjens; Govert J van Dam; Lisette van Lieshout; Meta Roestenberg
Journal:  J Travel Med       Date:  2020-07-14       Impact factor: 8.490

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.